FDA Alerts

Cancer
Cancer
FDA Approves First Biosimilar Product In The US
03/06/2015
The FDA has approved Zarxio (filgrastim-sndz), the first biosimilar product to be released in the United States, for indications including certain patients with cancer, leukemia, and neutropenia.
03/06/2015
testosterone
testosterone
FDA: Testosterone Therapy May Increase CV Risk
03/04/2015
The FDA announced new label requirements for testosterone therapy drugs warning of possible cardiovascular risks.
03/04/2015
FDA
FDA
FDA Approves New Combo Antibacterial Drug
03/02/2015
Researchers approved a new combination drug for the treatment of intra-abdominal and complicated urinary tract infections.
03/02/2015
venous thromboembolism
venous thromboembolism
FDA Approves New System for Varicose Vein Treatment
02/27/2015
The FDA has approved a new option for the treatment of individuals with symptomatic superficial varicose veins of the legs.
02/27/2015
FDA Alerts
FDA Alerts
In landmark FDA tobacco study, e-cig questions likely to linger
02/27/2015
...
02/27/2015
FDA Alerts
FDA Alerts
Long-acting contraceptives work beyond FDA-approved duration
02/10/2015
...
02/10/2015
Diabetes Q&A
Diabetes Q&A
FDA Approves New Combo Pill For Type 2 Diabetes
02/03/2015
The FDA approved the once-daily combination pill, Glyxambi, for the treatment of patients with type 2 diabetes.
02/03/2015
Addiction
Addiction
FDA approves ADHD drug Vyvanse for binge-eating disorder
02/02/2015
The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.
02/02/2015
FDA Alerts
FDA Alerts
U.S. FDA approves combination HIV pills
01/30/2015
By Reuters Staff
01/30/2015
Heart
Heart
FDA Roundup: New Options for Right Heart Failure, Waldenström’s, GERD
01/30/2015
The FDA has approved new options for right heart failure, GERD, and Waldenström’s macroglobulinemia that primary care providers should be aware of.
01/30/2015